Publisher
Massachusetts Medical Society
Cited by
299 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial;The Lancet;2024-09
2. Synthesis of substituted terpyridine nickel nitrate complexes and their inhibitory selectivity against cancer cell lines;Journal of Inorganic Biochemistry;2024-07
3. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial;The Lancet;2024-04
4. Simultaneous catheter and multicriteria optimization for HDR cervical cancer brachytherapy with a complex intracavity/interstitial applicator;Medical Physics;2023-12-03
5. NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024;Journal of the National Comprehensive Cancer Network;2023-12